Critical Issues in Causation and Treatment of Autism: Why Fads Continue to Flourish

REFERENCES

• American Association on Mental Retardation . ( 1994 , June ). Position statement on facilitated communication. Retrieved from http://www.baam.emich.edu/baam-sciencewatch/baamfcresolutions.htm#aamr
   Google Scholar
• American Psychiatric Association . ( 1994 ). Diagnostic and statistical manual of mental disorders () , 4th ed. . Washington , DC : Author .
   Google Scholar
• Biklen , D. ( 1990 ). Communication unbound: Autism and praxis . Harvard Educational Review , 60 , 291 – 314 .
   Web of Science ®Google Scholar
• Bligh , S. , & Kupperman , P. ( 1993 ). Facilitated communication evaluation procedure accepted in a court case . Journal of Autism and Developmental Disorders , 23 , 553 – 557 .
   PubMed Web of Science ®Google Scholar
• Celiberti , D. , Buchanan , S. , Bleecker , F. , Kreiss , D. , & Rosenfeld , D. ( 2004 ). The road less traveled: Charting a clear course for autism treatment. In Autism: Basic information (pp. 17–31). Robbinsville, NJ: Autism New Jersey.
   Google Scholar
• Centers for Disease Control, & Prevention . ( 2010 ). Autism and Developmental Disabilities Monitoring (ADDM) Network. Retrieved from http://www.cdc.gov/ncbddd/autism/addm.html
   Google Scholar
• Children's Hospital of Philadelphia . ( 2010 ). Vaccine education center. Retrieved from http://www.chop.edu/service/vaccine-education-center/vaccine-schedule/ vaccine-timetable.html
   Google Scholar
• Coniglio , S. J. , Lewis , J. D. , Lang , C. , Burns , T. G. , Subhani-Siddique , R. , Weintraub , A. , …Holden , E. W. ( 2001 ). A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism . The Journal of Pediatrics , 138 ( 5 ), 649 – 655 .
   Web of Science ®Google Scholar
• Coplan , J. , Souders , M. C. , Mulberg , A. E. , Belchic , J. K. , Wray , J. , Jawad , A. F. , …Levy , S. E. ( 2003 ). Children with autistic spectrum disorders II: Parents are unable to distinguish secretin from placebo under double-blind conditions . Archives of Disease in Childhood , 88 , 737 – 739 .
   PubMed Web of Science ®Google Scholar
• Dachel , A. ( 2010 , February 11 ). The Wakefield saga: 2004 all over again. The New York Times. Retrieved from http://www.ageofautism.com/2010/02/the-wakefield-saga-2004-all-over-again.html
   Google Scholar
• Dunn-Geier , J. , Ho , H. H. , Auersperg , E. , Doyle , D. , Eaves , L. , Matsuba , C. , …Whiting , S. ( 2000 ). Effect of secretin on children with autism: a randomized controlled trial . Developmental Medicine and Child Neurology , 42 ( 12 ), 796 – 802 .
   Web of Science ®Google Scholar
• Eberlin , M. , McConnachie , G. , Ibel , S. , & Volpe , L. ( 1993 ). Facilitated communication: A failure to replicate the phenomenon . Journal of Autism and Developmental Disorders , 23 , 507 – 530 .
   PubMed Web of Science ®Google Scholar
• Elder , J. H. , Shankar , M. , Shuster , J. , Theriaque , D. , Burns , S. , & Sherrill , L. ( 2006 ). The gluten-free, casein-free diet in autism: Results of a preliminary double-blind clinical trial . Journal of Autism and Developmental Disorders , 36 , 413 – 420 .
   PubMed Web of Science ®Google Scholar
• Favell , J. E. ( 2005 ). Sifting sound practice from snake oil . In J. Jacobson , R. Foxx , & J. Mulick (Eds.), Controversial therapies for developmental disabilities: Fad, fashion and science in professional practice (pp. 19 – 30 ). Mahwah , NJ : Lawrence Erlbaum .
   Google Scholar
• Gorman , B. J. ( 1998 ). Facilitated communication in America: Eight years and counting . Skeptic , 6 ( 3 ), 64 – 71 .
   Google Scholar
• Heward , W. L. ( 2009 ). Exceptional children: An introduction to special education . Upper Saddle River , NJ : Pearson .
   Google Scholar
• Horvath , K. , Stefanatos , G. , Sokolski , K. N. , Wachtel , R. , Nabors , L. , & Tildon , J. T. (1998). Improved social and language skills after secretin administration in patients with autistic spectrum disorders. Journal of the Association for Academic Minority Physicians , 9, 9–15.
   PubMedGoogle Scholar
• Hudson , A. , Melita , B. , & Arnold , N. ( 1993 ). Brief report: A case study assessing the validity of facilitated communication . Journal of Autism and Developmental Disabilities , 23 , 165 – 173 .
   PubMed Web of Science ®Google Scholar
• Huijbregts , S. C. J. , DeSonneville , L. M. J. , Licht , R. , Van Spronsen , F. J. , & Sergeant , J. ( 2002 ). Short-term dietary interventions in children and adolescents with treated phenylketonuria: Effects on neuropsychological outcome of a well-controlled population . Journal of Inherited Metabolic Diseases , 25 , 419 – 430 .
   PubMed Web of Science ®Google Scholar
• Humphries , T. L. ( 2003 ). Effectiveness of dolphin-assisted therapy as a behavioral intervention for young children with disabilities. Retrieved from http://www.riverbendds.org/index.htm?page=humphries.html
   Google Scholar
• Jacobson , J. W. , Foxx , R. M. , & Mulick , J. A. ( 2005 ). Facilitated communication: The ultimate fad treatment . In J. Jacobson , R. Foxx , & J. Mulick (Eds.), Controversial therapies for developmental disabilities: Fad, fashion, and science in professional practice (pp. 363 – 384 ). Mahwah , NJ : Lawrence Erlbaum .
   Google Scholar
• Kane , K. , & Linn , V. ( 2005 , August 25 ). Boy dies during autism treatment. Pittsburgh Post Gazette. Retrieved from http://www.post-gazette.com/pg/05239/561077-85.stm
   Google Scholar
• Klewe , L. ( 1993 ). An empirical evaluation of spelling boards as a means of communication for the multihandicapped . Journal of Autism and Developmental Disabilities , 23 , 559 – 566 .
   PubMed Web of Science ®Google Scholar
• Levy , S. E. , & Hyman , S. L. ( 2005 ). Novel treatments for autistic spectrum disorders . Mental Retardation and Developmental Disabilities Research Reviews , 11 , 131 – 142 .
   PubMedGoogle Scholar
• Maine Department of Education, & Maine Department of Health, & Human Services . ( 2009 , October ). Interventions for autism spectrum disorders: State of the evidence. Report of the Children's Services Evidence-Based Practice Advisory Committee. Retrieved from http://www.maine.gov/dhhs/ocfs/cbhs/ebpac/asd-report.doc
   Google Scholar
• Marino , L. , & Lilienfeld , S. ( 1998 ). Dolphin-assisted therapy: Flawed data, flawed conclusions . Anthrozoös , 11 , 194 – 199 .
   Web of Science ®Google Scholar
• Marino , L. , & Lilienfeld , S. ( 2007 ). Dolphin-assisted therapy: More flawed data, more flawed conclusions . Anthrozoös , 20 , 239 – 249 .
   Web of Science ®Google Scholar
• McCarthy , J. , & Carrey , J. ( 2008 , April 4 ). Jenny McCarthy: My son's recovery from autism. Retrieved from http://edition.cnn.com/2008/US/04/02/mccarthy.autism treatment/index.html
   Google Scholar
• Metz , B. , Mulick , J. A. , & Butler , E. M. ( 2005 ). Autism: A late 20th century fad magnet . In J. Jacobson , R. Foxx , & J. Mulick (Eds.), Controversial therapies for developmental disabilities: Fad, fashion, and science in professional practice (pp. 237 – 264 ). Mahwah , NJ : Lawrence Erlbaum .
   Google Scholar
• Molloy , C. A. , Manning-Courtney , P. , Swayne , S. , Bean , J. , Brown , J. M. , Murray , D. S. , …Ulrich , C. D. ( 2002 ). Lack of benefit of intravenous synthetic human secretin in the treatment of autism . Journal of Autism & Developmental Disorders , 32 , 545 – 551 .
   Web of Science ®Google Scholar
• Mostert , M. P. (2001). Facilitated communication since 1995: A review of published studies. Journal of Autism and Developmental Disorders , 31, 287–313.
   PubMed Web of Science ®Google Scholar
• Mulloy , A. , Lang , R. , O'Reilly , M. , Sigafoos , J. , Lancioni , G. , & Rispoli , M. ( 2011 ). Gluten-free and casein-free diets in the treatment of autism spectrum disorders: A systematic review . Research in Autism Spectrum Disorders , 5 ( 1 ), 86 – 88 .
   Web of Science ®Google Scholar
• National Institute of Mental Health . ( 2008 ). Autism chelation trial scrapped . New Scientist , 199 , ( 2675 ).
   Google Scholar
• Nelson , K. B. , & Bauman , M. L. ( 2003 ). Thimerosal and autism? Pediatrics , 111 ( 3 ), 674 – 679 .
   Web of Science ®Google Scholar
• Newsom , C. , & Hovanitz , C. A. ( 2005 ). The nature and values of empirically validated interventions . In J. W. Jacobson , R. M. Foxx , & J. A. Mulick (Eds.), Controversial therapies for developmental disabilities: Fad, fashion, and science in professional practice (pp. 31 – 44 ). Mahwah , NJ : Lawrence Erlbaum .
   Google Scholar
• Nicoll , A. , Elliman , D. , & Ross , E. ( 1998 ). MMR vaccination and autism . British Medical Journal , 316 , 715 – 716 .
   Web of Science ®Google Scholar
• Offit , P. A. , & Jew , R. K. ( 2003 ). Addressing parents concerns: Do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics , 112 ( 6 ), 1394 – 1401 .
   PubMed Web of Science ®Google Scholar
• Omer , S. B. , Salmon , D. A. , Orenstein , W. A. , deHart , M. P. , & Halsey , N. ( 2009 ). Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases . The New England Journal of Medicine , 350 ( 19 ), 1981 – 1988 .
   Google Scholar
• Prieto v. County of Orange, 1997 WL 399662, 95 Civ. 3755 (S.D.N.Y. 1997) .
   Google Scholar
• Reichow , B. , Volkmar , F. R. , & Cicchetti , D. V. ( 2008 ). Development of the evaluative method for evaluating and determining evidence-based practices in autism . Journal of Autism & Developmental Disorders , 38 , 1311 – 1319 .
   PubMed Web of Science ®Google Scholar
• Rockoff , J. D. ( 2010 , July 6 ). More parents seek vaccine exemptions. Wall Street Journal, pp. A4–A5.
   Google Scholar
• Sandler , A. D. , Sutton , K. A. , DeWeese , J. , Girardi , M. A. , Sheppard , V. , & Bodfish , J. W. ( 1999 ). Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder . New England Journal of Medicine , 341 , 1801 – 1806 .
   PubMed Web of Science ®Google Scholar
• Sinha , Y. , Silove , N. , & Williams , K. ( 2006 ). Chelation therapy and autism . British Journal of Medicine , 333 ( 7571 ), 756 .
   Web of Science ®Google Scholar
• Smith , P. J. , Chu , S. Y. , & Barker , L. E. ( 2004 ). Children who have received no vaccines: Who are they and where do they live? Pediatrics , 114 ( 1 ), 187 – 195 .
   PubMed Web of Science ®Google Scholar
• Smith , T. ( 2005 ). The appeal of unvalidated treatments . In J. Jacobson , R. Foxx , & J. Mulick (Eds.), Controversial therapies for developmental disabilities: Fad, fashion, and science in professional (pp. 45 – 60 ). Mahwah , NJ : Lawrence Erlbaum .
   Google Scholar
• Stehr-Green , P. , Tull , P. , Stellfeld , M. , Mortenson , P. B. , & Simpson , D. ( 2003 ). Autism and thimerosal-containing vaccines: Lack of consistent evidence for an association . American Journal of Preventative Medicine , 25 ( 2 ), 101 – 106 .
   Web of Science ®Google Scholar
• Tsouderos , T. ( 2010 , October 14 ). FDA cracks down on autism treatment. Chicago Tribune. Retrieved from http://articles.chicagotribune.com/2010-10-14/health/ct-met-fda-autism-chelation-20101014_1_chelation-treatment-warning-letter-fda-cracks
   Google Scholar
• Vyse , S. (2005). Where do fads come from?. In J. Jacobson , R. Foxx , & J. Mulick (Eds.), Controversial therapies for developmental disabilities: Fad, fashion, and science in professional practice (pp. 3–18). Mahwah , NJ : Lawrence Erlbaum.
   Google Scholar
• Wang , S. S. ( 2010 , February 3 ). Lancet retracts study tying vaccine to autism. Wall Street Journal. Retrieved from http://online.wsj.com/article/SB10001424052748704022804575041212437364420.html
   Google Scholar
• Zane , T. ( 2005 ). Fads in special education: An overview . In J. Jacobson , R. Foxx , & J. Mulick (Eds.), Controversial therapies for developmental disabilities: Fad, fashion, and science in professional practice (pp. 175 – 192 ). Mahwah , NJ : Lawrence Erlbaum .
   Google Scholar